Advertisement
Advertisement

HUMA

HUMA logo

Humacyte, Inc. Common Stock

1.06
USD
Sponsored
-0.02
-1.85%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

1.04

-0.02
-1.42%

Humacyte, Inc. Common Stock Profile

About

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Info & Links

CEO

Laura E. Niklason

Headquarters

2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.humacyte.com

Auditor

PricewaterhouseCoopers LLP

Share holders

180

Employees

184

Humacyte, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

232.01M

Enterprise Value

246.36M

Enterprise Value/EBITDA(ttm)

-2.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

66.13

Price to Book(mrq)

37.68

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-419.62%

Operating Margin(ttm)

-4672.08%

Profit Margin(ttm)

-3144.32%

Return on Equity(ttm)

-990.48%

Return on Invested Capital(ttm)

-270.11%

Return on Assets(ttm)

-74.79%

Income Statement

Revenue(ttm)

2.04M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

-7.66M

EBITDA(ttm)3

-100.79M

Net Income Available to Common(ttm)

-40.83M

Diluted EPS(ttm)

-0.20

Share Statistics

Beta (5Y Monthly)

2.11

52-Week Change

-12.40%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

222.02M

Dividend Yield

0.00%

Float4

210.70M

% Held by Insiders

5.10%

% Held by Institutions

44.71%

Balance Sheet

Total Cash(mrq)

50.50M

Total Cash Per Share(mrq)

0.23

Total Debt(mrq)

64.85M

Total Debt/Equity(mrq)

2085.75%

Current Ratio(mrq)

3.69%

Quick Ratio(mrq)

2.95%

Book Value Per Share(mrq)

0.02

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.66

Free Cash Flow(ytd)

-105.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement